LABD:NYE-Direxion Daily S&P Biotech Bear 3X Shares (USD)

ETF | Trading--Inverse Equity | NYE

Last Closing Price

USD 22.89

Change

0.00 (0.00)%

Market Cap

USD 0.07B

Volume

8.67M

Average Target Price

N/A
Average Analyst Rating

N/A

Fundamental Analysis

Verdict

About

The investment seeks daily investment results, before fees and expenses, of 300% of the inverse of the daily performance of the S&P Biotechnology Select Industry Index. The fund, under normal circumstances, invests in swap agreements, futures contracts, short positions or other financial instruments that, in combination, provide inverse (opposite) or short leveraged exposure to the index equal to at least 80% of the fund's net assets (plus borrowing for investment purposes). The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS). The fund is non-diversified.

Company Website : http://www.direxionfunds.com

Currency: USD

Country : USA

Inception Date: 28/05/2015

Primary Benchmark: S&P Biotechnology Select Industry TR USD

Primary Index: S&P 500 TR USD

Management Expense Ratio: 1.06 %

Technical Indicators

Beta : -2.75

52 Week High : 575.00

52 Week Low : 12.30

200 Day Moving Average : 37.94

50 Day Moving Average : 17.64

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
NVTA Invitae Corporation 1.95 %
EXEL Exelixis, Inc 1.91 %
BMRN BioMarin Pharmaceutical Inc 1.89 %
BLUE bluebird bio, Inc 1.87 %
GBT Global Blood Therapeutics, Inc 1.87 %
VRTX Vertex Pharmaceuticals Incorporated 1.84 %
SAGE Sage Therapeutics, Inc 1.80 %
UTHR United Therapeutics Corporation 1.78 %
REGN Regeneron Pharmaceuticals, Inc 1.77 %
ALXN Alexion Pharmaceuticals, Inc 1.76 %
Top Sectors

N/A

Top Regions

N/A

Valuation Growth & Performance

Morningstar Ratio : 0

Category Benchmark : S&P 500 TR USD

Sustainability Ratio :

3 Year Volatility : 78.55

3 Year Expected Return : 0.00

3 Year Sharpe Ratio : -1.03

YTD Return : -29.96%

3 Year Returns : -69.64%

5 Year Returns : -73.74%

10 Year Returns : 0.00%

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-03-07 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SH ProShares Short S&P500 0.90 %

N/A

 USD1.76B
SDS ProShares UltraShort S&P500 0.91 %

N/A

 USD0.74B
SPXU ProShares UltraPro Short S&P50.. 0.93 %

N/A

 USD0.61B
PSQ ProShares Short QQQ 0.95 %

N/A

 USD0.58B
SPXS Direxion Daily S&P 500 Bear 3X.. 1.07 %

N/A

 USD0.51B
SDOW ProShares UltraPro Short Dow30 0.95 %

N/A

 USD0.49B
TZA Direxion Daily Small Cap Bear .. 1.07 %

N/A

 USD0.39B
CHAD Direxion Daily CSI 300 China A.. 0.85 %

N/A

 USD0.32B
DOG ProShares Short Dow30 0.95 %

N/A

 USD0.30B
RWM ProShares Short Russell2000 0.95 %

N/A

 USD0.29B

ETFs Containing LABD

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Trading--Inverse Equity)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.42% 52% F 9% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.42% 52% F 8% F
Trailing 12 Months  
Capital Gain -91.38% 10% F N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -91.38% 10% F N/A N/A
Trailing 5 Years  
Capital Gain -99.81% 4% F N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -99.81% 4% F N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -58.63% 3% F N/A N/A
Dividend Return 0.48% 66% D 12% F
Total Return -58.15% 3% F N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.96% 27% F 27% F
Risk Adjusted Return -215.70% 13% F N/A N/A
Market Capitalization 0.07B 69% D+ 13% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.